The global regulatory experts at Modality Solutions provide a detailed, tactical approach for meeting the new requirements for container closure integrity (CCI) of sterile pharmaceutical products detailed in the revised Annex 1 EU GMP.
Download the slide deck created by industry experts, Andrew Larrigan and Carson Dickey to understand how the changes to EU Annex 1 will impact your cold chain strategy for container closure integrity.
Today, four leading life science companies—Suttons Creek, Modality Solutions, CLINTREX, and ToxStrategies—announce their unification...
read Details
Ensuring the safe, effective delivery of small molecule drugs is more challenging than ever....
read Details
At a Glance: Cold Chain Engineering: Modality Solutions focuses on enhancing drug delivery through...
read Details
